These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37144832)

  • 1. Validation of a new strategy for the identification of SARS-CoV-2 variants by sequencing the spike gene by Sanger.
    Murillo E; Palacio-Rua K; Afanador-Ayala C; García-Correa JF; Zuluaga AF
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 May; 41(5):284-289. PubMed ID: 37144832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of a new strategy for the identification of SARS-CoV-2 variants by sequencing the spike gene by Sanger].
    Murillo E; Palacio-Rua K; Afanador-Ayala C; García-Correa JF; Zuluaga AF
    Enferm Infecc Microbiol Clin; 2023 May; 41(5):284-289. PubMed ID: 35602577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
    Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
    Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 spike gene Sanger sequencing methodology to identify variants of concern.
    Alhamlan FS; Bakheet DM; Bohol MF; Alsanea MS; Alahideb BM; Alhadeq FM; Alsuwairi FA; Al-Abdulkareem MA; Asiri MS; Almaghrabi RS; Altamimi SA; Mutabagani MS; Althawadi SI; Al-Qahtani AA
    Biotechniques; 2023 Feb; 74(2):69-75. PubMed ID: 36794696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Despite low viral titer in saliva samples, Sanger-based SARS-CoV-2 spike gene sequencing is highly applicable for the variant identification.
    Ko K; Takahashi K; Ito N; Sugiyama A; Nagashima S; Miwata K; Kitahara Y; Okimoto M; Ouoba S; Akuffo GA; E B; Akita T; Takafuta T; Tanaka J
    BMC Med Genomics; 2023 Aug; 16(1):199. PubMed ID: 37620887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida.
    Carattini YL; Griswold A; Williams S; Valiathan R; Zhou Y; Shukla B; Abbo LM; Parra K; Jorda M; Nimer SD; Sologon C; Gallegos HR; Weiss RE; Ferreira T; Memon A; Paige PG; Thomas E; Andrews DM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SARS-CoV-2 Variants of Concern Using Amplicon Next-Generation Sequencing.
    Nasereddin A; Golan Berman H; Wolf DG; Oiknine-Djian E; Adar S
    Microbiol Spectr; 2022 Aug; 10(4):e0073622. PubMed ID: 35758686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan.
    Ko K; Takahashi K; Nagashima S; E B; Ouoba S; Hussain MRA; Akita T; Sugiyama A; Sakaguchi T; Tahara H; Ohge H; Ohdan H; Kubo T; Ishikawa N; Takafuta T; Fujii Y; Mimori M; Okada F; Kishita E; Ariyoshi K; Kuwabara M; Tanaka J
    Sci Rep; 2022 Feb; 12(1):2419. PubMed ID: 35165301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the epidemiological surveillance of SARS-CoV-2 using Sanger sequencing to identify circulating variants and recombinants.
    Silva T; Oliveira E; Oliveira A; Menezes A; Jeremias WJ; Grenfell RF; Monte-Neto RLD; Pascoal-Xavier MA; Campos MA; Fernandes G; Alves P
    Braz J Microbiol; 2024 Sep; 55(3):2085-2099. PubMed ID: 38802687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tool for the cheap and rapid screening of SARS-CoV-2 variants of concern (VoCs) by Sanger sequencing.
    Burgos G; Ambuludí A; ; Morales-Jadán D; Garcia-Bereguiain MA; Muslin C; Armijos-Jaramillo V
    Microbiol Spectr; 2023 Sep; 11(5):e0506422. PubMed ID: 37676038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercising the Sanger Sequencing Strategy for Variants Screening and Full-Length Genome of SARS-CoV-2 Virus during Alpha, Delta, and Omicron Outbreaks in Hiroshima.
    Ko K; Takahashi K; Nagashima S; E B; Ouoba S; Takafuta T; Fujii Y; Mimori M; Okada F; Kishita E; Ariyoshi K; Hussain MRA; Sugiyama A; Akita T; Kuwabara M; Tanaka J
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Variants of Concern: Presumptive Identification via Sanger Sequencing Analysis of the Receptor Binding Domain (RBD) Region of the
    Rodrigues GM; Volpato FCZ; Wink PL; Paiva RM; Barth AL; de-Paris F
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
    Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
    Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast detection of SARS-CoV-2 variants including Omicron using one-step RT-PCR and Sanger sequencing.
    Bloemen M; Rector A; Swinnen J; Ranst MV; Maes P; Vanmechelen B; Wollants E
    J Virol Methods; 2022 Jun; 304():114512. PubMed ID: 35257682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking SARS-CoV-2 variants by entire S-gene analysis using long-range RT-PCR and Sanger sequencing.
    Matsubara M; Imaizumi Y; Fujikawa T; Ishige T; Nishimura M; Miyabe A; Murata S; Kawasaki K; Taniguchi T; Igari H; Matsushita K
    Clin Chim Acta; 2022 May; 530():94-98. PubMed ID: 35304093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Sanger approach based on overlapping fragments to screen SARS-CoV-2 variants.
    Lekana-Douki SE; Mangombi Pambou JB; N'dilimabaka N; Zong Minko O; Andeko JC; Ngonga Dikongo AM; Edang Minko A; Lekana-Douki JB
    Heliyon; 2023 Dec; 9(12):e23039. PubMed ID: 38076162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Sanger sequencing to recover key mutations in SARS-CoV-2 variant genome assemblies produced by next-generation sequencing.
    Singh L; San JE; Tegally H; Brzoska PM; Anyaneji UJ; Wilkinson E; Clark L; Giandhari J; Pillay S; Lessells RJ; Martin DP; Furtado M; Kiran AM; de Oliveira T
    Microb Genom; 2022 Mar; 8(3):. PubMed ID: 35294336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern.
    Yan T; Xu Y; Zheng R; Zeng X; Chen Z; Lin S; Xia Z; Liao Y; Zhang Y; Li Q
    Microbiol Spectr; 2022 Oct; 10(5):e0322222. PubMed ID: 36106882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of EPISEQ SARS-CoV-2 and a Fully Integrated Application to Identify SARS-CoV-2 Variants from Several Next-Generation Sequencing Approaches.
    Mugnier N; Griffon A; Simon B; Rambaud M; Regue H; Bal A; Destras G; Tournoud M; Jaillard M; Betraoui A; Santiago E; Cheynet V; Vignola A; Ligeon V; Josset L; Brengel-Pesce K
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.